Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Paradoxical Lucidity Could Help Explain Dementia Pathophysiology

By HospiMedica International staff writers
Posted on 10 Jul 2019
A new study outlines what is known and unknown about paradoxical lucidity, the phenomena of unexplained clarity that many dementia patients experience at end of life.

Researchers at Duke University (Durham NC, USA), the University of Pennsylvania (Philadelphia, PA, USA), and other institutions participating in an interdisciplinary workgroup convened by the U.S. More...
National Institute on Aging (Bethesda, MD, USA) conducted a study to review what is known about paradoxical lucidity, related phenomena that provide insight into potential mechanisms, ethical implications, and methodologic considerations for systematic investigation.

The study describes earlier work documenting case studies of individuals with advanced dementia, including Alzheimer's disease (AD), appearing to be able to communicate with their family and recall in a seemingly normal fashion at the end of life, to the astonishment of their caregivers. The researchers warned, however, that studying paradoxical lucidity would be a challenge, given the fleeting nature of the event, with case studies reporting episodes lasting from mere seconds to at most several days in a small minority of cases.

The researchers conclude that paradoxical lucidity, if systematically confirmed, challenges current assumptions and highlights the possibility of network-level return of cognitive function in cases of severe dementias, which can provide insight into both underlying neurobiology and future therapeutic possibilities. The workgroup also outlined ethical implications, including the ability of vulnerable patients to participate in research, and how observation of paradoxical lucidity might change the way caregivers interact with people with dementia. The study was published in the August 2019 issue of Alzheimer's & Dementia.

“We've assumed that advanced dementia is an irreversible neurodegenerative process with irreversible functional limitations,” said lead author Professor George Mashour, MD, PhD, director of the Center for Consciousness Science at Duke University. “But if the brain is able to access some sort of functional network configuration during paradoxical lucidity, even in severe dementia, this suggests a reversible component of the disease.”

“Would research that might identify a systematically observable paradoxical lucidity provide comfort, for example, by offering loved ones a potential channel for closure, or might it induce worry if loved ones are left to wonder if a reversible cause of the dementia could have been found?” said co-first author Lori Frank, PhD, of the RAND Corporation (Pittsburgh, PA, USA), and former Health and Aging Congressional fellow with the National Institute on Aging. “We do not know the answers but these could be important research questions in their own right.”

Related Links:
Duke University
University of Pennsylvania
U.S. National Institute on Aging

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.